跳至主要内容
临床试验/JPRN-jRCT1021230018
JPRN-jRCT1021230018尚未招募Unknown

Prospective intervention study of swallowing function improvement anti-gastric ulcer drugs in the elderly.

Seki Yumika0 个研究点目标入组 88 人开始时间: 2023年7月29日最近更新:

试验速览

阶段
Unknown
状态
尚未招募
发起方
入组人数
88

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 65age old 至 ot applicable(—)
性别
All

入选标准

  • Elderly people aged 65 years or older with a history of gastric ulcer who have subjective symptoms of swallowing dysfunction or who have been diagnosed with swallowing dysfunction, and who are taking antacids.

排除标准

  • 1.Difficult to take gastric ulcer drugs due to severe dementia or deterioration of consciousness.
  • 2.Patients with a history of limb amputation near the wrist or ankle.
  • 3.Continuously taking test drugs (polaprezinc, rebamipide) for more than 1 week within 2 weeks before informed consent.
  • 4.Have been hospitalized for more than 1 week within 2 weeks before informed consent.
  • 5.Patients who are judged to be unsuitable to participate in this study by the principal investigator or co-investigator.
  • 6.Patients who are allergic to test drugs (polaprezinc, rebamipide) .
  • 7.Patients who are judged to be difficult to participate in the study due to complication of psychosis or psychiatric symptoms.
  • 8.Patients who are judged to be unable to perform the test due to severe dementia, etc.

研究者

发起方
Seki Yumika

相似试验